Investigational Drug Information for Talinolol
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for Talinolol?
Talinolol is an investigational drug.
There have been 4 clinical trials for Talinolol.
The most recent clinical trial was a Phase 1 trial, which was initiated on June 1st 2007.
The most common disease conditions in clinical trials are Obesity, Morbid and [disabled in preview]. The leading clinical trial sponsors are University Medicine Greifswald, Matthias Schwab, and Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH.
Summary for Talinolol
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 784 |
WIPO Patent Applications | 483 |
Japanese Patent Applications | 2 |
Clinical Trial Progress | Phase 1 (2007-06-01) |
Vendors | 46 |
Recent Clinical Trials for Talinolol
Title | Sponsor | Phase |
---|---|---|
Open Label Study for the Functional Characterization of Drug Metabolism and Transport | Matthias Schwab | Phase 1 |
Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water | University Medicine Greifswald | Phase 1 |
Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | Phase 1 |
Clinical Trial Summary for Talinolol
Top disease conditions for Talinolol
Top clinical trial sponsors for Talinolol
US Patents for Talinolol
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |